Bloodwise
Posted by

Our new childhood cancer report highlights the need for more effective treatment

Bloodwise
Posted by
13 Sep 2017

Our major childhood cancer report states the need for more research to find better, less toxic treatments.

The cover of our new report
The cover of our new report

Today we launch a major report which states the need for more research to find better, less toxic treatments for children with blood cancer.

Childhood blood cancer; the quest for a kinder cure outlines the severe side effects which children on current treatments experience. It explores where breakthroughs are being made and how progress can be accelerated.

Blood cancer is the most common cancer among children and young people. Over 1,100 children and young people up to the age of 24 are diagnosed every year in the UK, usually with either acute lymphoblastic leukaemia or Hodgkin lymphoma. Current childhood blood cancer treatment is brutal and can last for years. In addition to hair loss, vomiting and fatigue, the treatments can also result in extended periods away from school, isolation, infertility and an increased risk of further cancer in adulthood.

Our director of research Dr Alasdair Rankin says: “The reality is that one in five children diagnosed with the most common type of leukaemia still do not survive, and that those who do often experience devastating side effects both during and after treatment.

"This is simply not good enough. We need to save every child’s life, make the treatment process much kinder and give them the life they would have had without cancer. Only by funding more research into better treatments will we be able to finish the job that has been started and give children the best possible cancer treatment.”

Download the full report

Comments

Related blogs